Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States

ConclusionsIn this study of the initial commercial U.S. experience, it was found that procedural success was achieved in approximately 91% of patients, and the majority of patients were discharged home with moderate or less MR. These data support the effectiveness of this therapy in appropriately selected high-risk patients in a commercial setting. Further study is required to determine the long-term impact of transcatheter MV repair in this patient population.
Source: Journal of the American College of Cardiology - Category: Cardiology Source Type: research